JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M702927200 on May 15, 2007

J. Biol. Chem., Vol. 282, Issue 28, 20447-20454, July 13, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/28/20447    most recent
M702927200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryder, J. W.
Right arrow Articles by Stull, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryder, J. W.
Right arrow Articles by Stull, J. T.
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Enhanced Skeletal Muscle Contraction with Myosin Light Chain Phosphorylation by a Calmodulin-sensing Kinase*{diamondsuit}

Jeffrey W. Ryder1, Kim S. Lau, Kristine E. Kamm, and James T. Stull2

From the Department of Physiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390

Received for publication, April 6, 2007 , and in revised form, May 8, 2007.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Repetitive low frequency stimulation results in potentiation of twitch force development in fast-twitch skeletal muscle due to myosin regulatory light chain (RLC) phosphorylation by Ca2+/calmodulin (CaM)-dependent skeletal muscle myosin light chain kinase (skMLCK). We generated transgenic mice that express an skMLCK CaM biosensor in skeletal muscle to determine whether skMLCK or CaM is limiting to twitch force potentiation. Three transgenic mouse lines exhibited up to 22-fold increases in skMLCK protein expression in fast-twitch extensor digitorum longus muscle containing type IIa and IIb fibers, with comparable expressions in slow-twitch soleus muscle containing type I and IIa fibers. The high expressing lines showed a more rapid RLC phosphorylation and force potentiation in extensor digitorum longus muscle with low frequency electrical stimulation. Surprisingly, overexpression of skMLCK in soleus muscle did not recapitulate the fast-twitch potentiation response despite marked enhancement of both fast-twitch and slow-twitch RLC phosphorylation. Analysis of calmodulin binding to the biosensor showed a frequency-dependent activation to a maximal extent of 60%. Because skMLCK transgene expression is 22-fold greater than the wild-type kinase, skMLCK rather than calmodulin is normally limiting for RLC phosphorylation and twitch force potentiation. The kinase activation rate (10.6 s-1) was only 3.6-fold slower than the contraction rate, whereas the inactivation rate (2.8 s-1) was 12-fold slower than relaxation. The slower rate of kinase inactivation in vivo with repetitive contractions provides a biochemical memory via RLC phosphorylation. Importantly, RLC phosphorylation plays a prominent role in skeletal muscle force potentiation of fast-twitch type IIb but not type I or IIa fibers.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Repetitive stimulation of fast-twitch skeletal muscle results in enhanced twitch force (1–3). This twitch force potentiation can be observed following a brief (1–2-s) high frequency stimulation sufficient to induce a tetanus (post-tetanic potentiation) or in response to continual low frequency (5–10-Hz) stimulation (staircase effect). The skMLCK3 is a Ca2+/CaM-dependent protein kinase that phosphorylates the fast-twitch skeletal muscle isoform of the myosin RLCf (4). Stimulation of fast-twitch skeletal muscle results in proportional RLCf phosphorylation and twitch force potentiation (3, 5). In skMLCK knock-out mice, RLCf is not phosphorylated in response to electrical stimulation and is accompanied by an ablation of post-tetanic twitch force potentiation and a markedly reduced staircase effect (6). These results clearly define skMLCK-mediated RLCf phosphorylation as the primary biochemical mechanism responsible for twitch force potentiation.

Post-activation potentiation in human skeletal muscle has recently received attention for its potential to affect human performance in strength and endurance exercise (7, 8). RLC phosphorylation increased eccentric contraction-induced injury in skinned fast-twitch fibers (9). Furthermore, single nucleotide polymorphisms for skMLCK were associated with increased sensitivity to exercise injury in humans (10).

The effect of repetitive stimulation to evoke RLCf phosphorylation and twitch force potentiation is much more pronounced in fast-twitch versus slow-twitch skeletal muscle. Investigations in mouse (11), rabbit (12), and rat (13) skeletal muscle all show a greater effect of electrical stimulation on the extent of RLC phosphorylation in fast-twitch versus slow-twitch muscle. When detectable, stimulation-induced RLC phosphorylation in slow-twitch muscle required higher frequencies and longer stimulation times than did fast-twitch muscle, conditions that typically lead to fatigue (11–13). Like-wise, twitch force potentiation was more robust in fast-versus slow-twitch muscle (13, 14). Reduced RLC phosphorylation may be due to lower skMLCK and greater myosin phosphatase activities in slow-twitch muscle (13). In skinned fast-twitch skeletal muscle and cardiac muscle fibers, RLC phosphorylation results in force potentiation (15). Therefore, overexpression of skMLCK in slow-twitch muscle is predicted to result in significant RLC phosphorylation, thereby producing twitch force potentiation.

CaM is limiting for activation of targeted enzymes in cells in culture (16) as well as smooth muscle (17). Thus, reduced skMLCK activation due to limiting Ca2+/CaM availability may affect the achievable extent of RLC phosphorylation in fast-twitch fibers and slow-twitch fibers in particular.

We generated transgenic mice that express an skMLCK CaM biosensor in both fast-twitch and slow-twitch skeletal muscle to determine 1) whether skMLCK is a limiting factor for RLC phosphorylation and twitch force potentiation in fast-twitch muscle, 2) whether elevating skMLCK levels in slow-twitch muscle is sufficient to enhance RLC phosphorylation and twitch force potentiation, and 3) whether CaM is rate-limiting to frequency-dependent activation of skMLCK in the intact muscle.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Generation of HSA-skKCS Mice—The pcDNA-skKCS plasmid was constructed by subcloning into pcDNA3.1 a 4.6-kb cDNA fragment encoding rabbit skMLCK fused to an MLCK CaM biosensor (18) followed by the human growth hormone polyadenylation sequence to form the plasmid pcDNA-skKCS. The MLCK CaM biosensor consists of an MLCK CaM binding site flanked by enhanced yellow fluorescent protein and enhanced cyan fluorescent protein. The human skeletal {alpha}-actin (HSA) promoter (19, 20) was subsequently subcloned into pcDNA-skKCS to generate the HSA-skKCS plasmid. HSA-skKCS was linearized by PmeI digestion. HSA-skKCS mice were generated at the University of Texas Southwestern Transgenic Core Facility by pronuclear injection of the linearized transgene construct followed by implantation of oocytes into pseudo-pregnant ICR mice. Founder mice were identified by PCR using primers directed against the rabbit skMLCK construct. Three independent lines were maintained on a C57BL/6 background. Mice from all lines appeared normal and showed no obvious phenotype. All animal experiments were conducted using protocols approved by the Institutional Animal Care and Use Committee.

Electrical Stimulation of Isolated Skeletal Muscle—EDL and soleus muscles were mounted to Grass FT03 force transducers between platinum electrodes and were immersed in continuously gassed physiological salt solution. Muscles remained quiescent for 30 min and were frozen immediately or following 3 or 15 s of 10-Hz electrical stimulation as described (6). Measurement of force development was recorded on a Powerlab 8/SP data acquisition unit (AD Instruments, Colorado Springs, CO). In both wild-type and transgenic soleus muscle, increased twitch force occurred rapidly within the first 0.5 s due to partial fusion of contractile force with 10-Hz electrical stimulation. Therefore, twitch force was normalized to the twitch occurring at 0.5 s (i.e. sixth twitch). Because of the potential for overexpressed green fluorescent protein containing proteins to interfere with muscle contraction by interacting with myosin (21), we determined that there was no difference in the initial twitch force properties without RLC phosphorylation of EDL muscles from wild-type or transgenic (line 3) mice.

Western Blot Analysis—Muscle proteins precipitated in 10% trichloroacetic acid were solubilized in urea sample buffer for separation of phosphorylated and non-phosphorylated RLC by urea/glycerol-PAGE (22). Proteins from EDL muscle were transferred to polyvinylidene difluoride membranes and probed with a polyclonal primary antibody (6). Because soleus muscle contains both RLCf and slow-twitch RLC (RLCs), two-dimensional electrophoresis was performed for the determination of RLC phosphorylation in soleus muscle. Urea/glycerol-PAGE was followed by SDS-PAGE on 15% resolving gels. Proteins were transferred and analyzed as described above. CaM was also analyzed by urea/glycerol-PAGE using a monoclonal CaM antibody with purified CaM as a standard. SDS-PAGE (7.5% resolving gels) was used for Western blotting of skMLCK using a goat polyclonal skMLCK antibody (23) and a rabbit polyclonal myosin phosphatase-targeting subunit (MYPT) 1/2 antibody (Epitomics). Membranes were incubated in the appropriate horseradish peroxidase-conjugated secondary antibody, and proteins were visualized using ECL Plus detected on the Storm 640.

Kinase Activity in Skeletal Muscle—A portion of white quadriceps muscle from wild-type or transgenic mice was weighed and homogenized (1:50, w/v) in ice-cold homogenization buffer (50 mM MOPS, 10% glycerol, 1 mM dithiothreitol, 4 mM EGTA, 50 mM KCl, 0.25 mM trans-epoxysuccinyl-L-leucyl-amido-(4-guanidino)-butane and 0.25 mM diisopropylfluorophosphate at pH 7.0). Homogenates were subjected to centrifugation at 12,000 x g for 10 min at 4 °C. Supernatant fractions were diluted to 1:2000–1:10,000 in 10 mM MOPS, 1 mM dithiothreitol, and 1 mM EGTA at pH 7.0. Aliquots of the supernatant fractions were used for measurements of kinase activity at 30 °C by 32P incorporation into purified RLC in the presence and absence of Ca2+/CaM where reactions were linear with time and proportional to extract dilution (13, 24).

Kinase Activity and FRET Analysis in COS Cells—COS cells were maintained at 37 °C with 5% CO2 in Dulbecco's modified Eagle's medium containing 4 mM L-glutamine, 1.5 g/liter sodium bicarbonate, 4.5 g/liter glucose, 1 mM sodium pyruvate, and 10% fetal bovine serum. Cells were plated in 35-mm dishes, and 24 h later, cells were transfected using Lipofectamine 2000 with 3 µg of plasmid DNA containing the skMLCK/CaM sensor sequence under control of the cytomegalovirus promoter. Extracts were prepared from cells 48 h after transfection, and kinase activity was determined with standard Ca2+-methane-sulfate solutions to achieve specific free Ca2+ concentrations as described (24). Additional aliquots of kinase extract were used for fluorescence resonance energy transfer (FRET) analysis using an excitation wavelength of 430 nm and emission wavelengths of 480 and 525 nm on a PerkinElmer Life Sciences 650-10S fluorescence spectrophotometer. Free Ca2+ concentrations were identical to those used for kinase activity measurements. In the absence of Ca2+, excitation of enhanced cyan fluorescent protein at 430 nm in CaM sensor skMLCK resulted in peak fluorescence emission at 525 nm from enhanced yellow fluorescent protein due to FRET. Upon Ca2+/CaM binding, FRET decreased with an increased emission at 480 nm and decreased emission at 525 nm. The emission spectrum of the skMLCK CaM sensor in the absence and presence Ca2+/CaM was similar to that previously reported for the sensor moiety linked to the smooth muscle MLCK (17, 23). The catalytic properties of the CaM sensor skMLCK were similar to wild-type skMLCK, which is similar to the comparison of smooth muscle MLCK with and without the biosensor (17, 23). Thus, the addition of the sensor moiety did not significantly change the catalytic properties of the kinase.

Measurement of skMLCK Activation by Electrical Stimulation in Intact Skeletal Muscle—Activation of skMLCK was measured in HSA-skMLCK (line 3) lumbrical muscles from the hind paw by FRET of the CaM biosensor using procedures similar to those described for kinase activation in bladder smooth muscle (17). Lumbrical muscles were mounted on a fluorescence myograph (Scientific Instruments, Heidelberg, Germany) in a cylindrical quartz cuvette and perfused with physiological salt solution. The muscle was excited at 436 nm, and emitted light was detected by two photomultipliers using 480- and 535-nm filters. The extent of skMLCK activation was determined from the 480/535-nm emission ratio (subjected to a 10-Hz low pass filter) of intact muscles electrically stimulated at 0.2–300 Hz. In a subset of experiments, muscles were permeabilized following electrical stimulation (10 and 150 Hz) with 100 µM beta-escin in the presence of 5 mM CaCl2 and 4 µM CaM, and the 480/535 nm ratio was continuously recorded digitally on a Powerlab 8/SP. Frequency-dependent activation of skMLCK was expressed as a percentage of the maximal Ca2+/CaM response. For rate constant studies, the emission ratio was measured without electronic filtering, and data were acquired at 10 kHz for muscles stimulated at 150 Hz for 0.5 s. Each muscle was stimulated a total of 30 times at 3-min intervals. Acquisitions were averaged after alignment to the initial stimulus pulse using a signal-averaging program written for Matlab. Rate constants were estimated by linear regression of points on the steepest rising and falling aspects. For graphic presentation, data were smoothed using Sigma Plot.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Myosin Light Chain Kinase Protein Expression and Enzymatic Activity—Skeletal muscle MLCK expression was determined in different tissues from skMLCK transgenic mice. The transgene for the skMLCK results in a larger molecular mass on SDS-PAGE due to the CaM biosensor. In tissue samples, transgene expression was readily evident in both fast-twitch (EDL and white quadriceps) and slow-twitch (soleus) skeletal muscle (Fig. 1A). Negligible to undetectable amounts of transgene were observed in heart, urinary bladder, liver, and kidney.

Quantitative analysis by Western blotting was performed in EDL and soleus muscles for the three lines of transgenic mice. In EDL muscle, the amount of total skMLCK (endogenous plus transgenic) was 3.8 ± 0.1-, 17.7 ± 2.2-, and 22.5 ± 0.9-fold greater than wild-type EDL expression for lines 1, 2, and 3, respectively (Fig. 1B). The amount of endogenous skMLCK in EDL muscle was similar between wild-type and transgenic mice in line 1. Conversely, endogenous skMLCK was reduced by 75% in line 2 and 78% in line 3. Expression of skMLCK in soleus muscle from wild-type mice was 14% of wild-type EDL expression. Soleus skMLCK expression in transgenic mice was equal to 1.5 ± 0.2-, 11.9 ± 0.8-, and 16.2 ± 1.6-fold of wild-type EDL. Endogenous expression of skMLCK in soleus muscle was similar between wild-type and transgenic mice from line 1, whereas endogenous skMLCK was not detected in transgenic mice for lines 2 and 3. Thus, the three transgenic lines expressed skMLCK in different amounts greater than endogenous skMLCK with comparable amounts in fast- and slow-twitch muscles. The high amounts of transgene expression in lines 2 and 3 resulted in decreased expression of endogenous skMLCK in both fast-twitch and slow-twitch muscles.


Figure 1
View larger version (28K):
[in this window]
[in a new window]

  		FIGURE 1.
Skeletal muscle MLCK protein expression and kinase activity. A, Western blot for skMLCK in different tissues from transgenic line 1 and in wild-type (WT) EDL muscle. The upper arrow indicates transgenic skMLCK-CaM sensor, and the lower arrow indicates endogenous skMLCK protein. Quad, quadriceps muscle. B, quantification of total skMLCK in wild-type and transgenic (TG) EDL and soleus muscle (Sol) from line 1 (open bars), line 2 (hatched bars), and line 3 (closed bars). C, kinase activity was determined in skMLCK extracts from a portion of white quadriceps muscle from line 1 (open bars), line 2 (hatched bars), and line 3 (closed bars). Results are expressed as relative to wild-type mice. Values represent mean ± S.E. (n = 6–9). *, p < 0.05, **, p < 0.0001 versus wild-type.

 
Skeletal muscle MLCK enzymatic capacity was determined in extracts prepared from fast-twitch quadriceps muscle from wild-type and transgenic mice by 32P incorporation into purified RLCf. Skeletal muscle MLCK activity was elevated 1.3 ± 0.1-, 12.3 ± 0.9-, and 15.3 ± 2.0-fold in transgenic mice from lines 1, 2, and 3, respectively (Fig. 1C). The results from enzymatic measurements of kinase activities are consistent with the expression amounts measured by Western blotting.


Figure 2
View larger version (25K):
[in this window]
[in a new window]

  		FIGURE 2.
Calmodulin and MYPT1/2 protein expression. A, protein expression of calmodulin in wild-type (WT) and skMLCK transgenic EDL and soleus muscle (line 3). The gel inset shows a representative CaM blot from extracts of wild-type EDL, transgenic EDL, wild-type soleus, and transgenic soleus muscles (Sol), respectively. B, protein expression of MYPT1 (closed bars) and MYPT2 (open bars) in EDL and soleus muscles from wild-type and skMLCK transgenic mice (line 3). Samples shown in the representative Western blot images are loaded in the same order as presented in histograms. Values represent mean ± S.E. (n = 4).

 
Calmodulin and MYPT1/2 Expression—Protein expression of CaM was determined in EDL and soleus muscles from wild-type and transgenic mice from line 3 by Western blotting with purified bovine CaM as a standard. In EDL muscle, expression was 0.29 ± 0.02 versus 0.25 ± 0.02 ng of CaM/µg of total protein for wild-type and transgenic mice (line 3), respectively (Fig. 2A). In soleus muscle, expression was 0.12 ± 0.01 versus 0.13 ± 0.02 ng of CaM/µg of total protein for wild-type and transgenic mice (line 3), respectively. Expression of MYPT1 and -2 was also determined in EDL and soleus muscles from wild-type and transgenic mice (line 3). In EDL muscles from both wild-type and transgenic mice, MYPT1 expression accounted for ~90% of total MYPT expression, whereas similar amounts of MYPT1 and -2 were observed in soleus muscles (Fig. 2B). Neither MYPT1 nor MYPT2 was significantly different between wild-type and transgenic mice in either muscle type. Thus, transgenic overexpression of skMLCK did not affect total amounts of CaM or MYPT1/2 in fast- or slow-twitch muscles.

Potentiation of Isometric Twitch Force and RLC Phosphorylation in Fast-twitch EDL Muscle—Low frequency stimulation of wild-type EDL muscle from each mouse line resulted in a progressive increase of twitch force. Following 15 s of 10-Hz stimulation, twitch force increased to greater than 50% in wild-type EDL muscle. EDL muscles from line 1 showed a similar staircase effect to wild-type mice (Fig. 3, A and B). Transgenic mice from line 3, the highest expressing line, displayed a more rapid increase in twitch force with significantly greater levels of potentiation at the 3–12-s measurements (Fig. 3, E and F). A similar effect was observed in transgenic mice from line 2 (data not shown). Following the maximal potentiation response, a small degree of fatigue was observed prior to 15 s in transgenic EDL muscles (Fig. 3, E and F). A similar response is observed in wild-type EDL muscles following maximal potentiation at 15 s (data not shown).

Phosphorylation of RLC was similar in EDL muscles in the quiescent state in both genotypes of all three lines. In line 1, there was a marginal but significant increase in RLCf phosphorylation in transgenic versus wild-type mice following 3 s of stimulation of EDL muscles (Fig. 3, C and D). No difference in RLCf phosphorylation between genotypes was observed following 15 s of stimulation. In line 3, RLCf was markedly increased versus wild-type after 3 s (0.36 ± 0.02 versus 0.56 ± 0.01 mol of phosphate/mol of RLCf for wild-type and transgenic mice, respectively) and 15 s of stimulation (0.52 ± 0.02 versus 0.71 ± 0.02 mol of phosphate/mol of RLCf for wild-type and transgenic mice, respectively, Fig. 3, G and H). Values similar to line 3 were observed for line 2 (data not shown). Thus, expression of skMLCK in fast-twitch muscle increases the rates of RLCf phosphorylation and twitch potentiation comparable with the greater amounts of kinase.

Potentiation of Isometric Twitch Force and RLC Phosphorylation in Slow-twitch Soleus Muscle—Maximal twitch potentiation in wild-type soleus muscle ranged from 1.08- to 1.14-fold. No significant difference between wild-type and transgenic soleus muscle contraction responses was observed at any of the indicated time points in transgenic line 1 (data not shown). In line 3, a small but significantly greater twitch potentiation (1.11 ± 0.04 versus 1.23 ± 0.04-fold, p < 0.05) was observed at 12 s (Fig. 3, I and J). In line 2, a similar minimal potentiation response was observed with significant differences observed at 6–12 s (data not shown).

Phosphorylation of RLCf and slow-twitch regulatory light chain (RLCs) was determined in soleus muscles from lines 3. In wild-type soleus muscle, electrical stimulation for 15 s increased RLCf phosphorylation from 0.08 ± 0.02 to 0.17 ± 0.02 mol of phosphate/mol of RLCf (Fig. 3, K and L). No increase in RLCf was observed after 3 s in wild-type mice. RLCf phosphorylation was increased in transgenic versus wild-type soleus after 3 and 15 s of stimulation. The maximal extent of RLCf phosphorylation in transgenic soleus muscles was 0.62 ± 0.05 mol of phosphate/mol of RLCf. RLCs was unaltered by electrical stimulation in wild-type soleus muscle, whereas phosphorylation rates increased in soleus muscles from transgenic animals from 0.10 ± 0.01 and 0.44 ± 0.02 mol of phosphate/mol of RLCs in response to 15 s of stimulation. Furthermore, RLCs phosphorylation was significantly greater in soleus muscle from transgenic versus wild-type mice following 3 and 15 s.


Figure 3
View larger version (70K):
[in this window]
[in a new window]

  		FIGURE 3.
Twitch force potentiation and RLC phosphorylation in fast- and slow-twitch skeletal muscle. A–D, responses for transgenic (TG) line 1. A, representative force tracings for fast-twitch EDL muscle from wild-type (upper panels) and transgenic (lower panels) mice. B, mean force development values for EDL muscle from wild-type (closed circles) and transgenic mice (open circles). C and D, representative Western blot image following urea/glycerol-PAGE (C) and mean values (D) for RLCf phosphorylation without electrical stimulation (open bars), or following 3 s (hatched bars) or 15 s(closed bars) of 10-Hz electrical stimulation. WT, wild type. E–L, responses from transgenic line 3. E, representative force tracings for EDL muscle from wild-type (upper panels) and transgenic (lower panels) mice. F, mean force development values for EDL muscle from wild-type (closed circles) and transgenic (open circles) mice. G and H, representative Western blot image following urea/glycerol-PAGE (G) and mean values (H) for RLCf phosphorylation in EDL without electrical stimulation (open bars) or following 3 s (hatched bars) or 15 s (closed bars) of 10-Hz electrical stimulation. I, representative force tracings for slow-twitch soleus muscle from wild-type (upper panels) and transgenic (lower panels) mice. J, mean force development values for soleus muscle from wild-type (closed circles) and transgenic mice (open circles). K, representative Western blot image following two-dimensional urea/glycerol-PAGE and SDS-PAGE for RLCf and RLCs phosphorylation in soleus muscle from wild-type and transgenic mice following 15 s of electrical stimulation at 10 Hz (arrowheads indicate phosphorylated forms of RLC). L, mean values for RLCf and RLCs phosphorylation without electrical stimulation (open bars) or following 3 s (hatched bars) or 15 s (closed bars) of electrical stimulation at 10 Hz. Values represent mean ± S.E. (n = 5–11 for B–J, n = 3–6 for L); *, p < 0.05, **, p < 0.0001 versus wild-type.

 
Activation of skMLCK in Response to Electrical Stimulation—We have used the CaM biosensor, which is part of the transgene construct, to measure skMLCK activation in response to repetitive electrical stimulation in intact lumbrical muscles. The utility of this biosensor as an indicator of skMLCK activation was demonstrated in transfected COS cells. Binding of Ca2+/CaM to the biosensor measured by FRET and kinase activation determined by 32P incorporation into purified RLCf showed similar calcium dependence (Fig. 4A). Thus, the change in FRET measures Ca2+/CaM binding coincident to kinase activation. Similar results were reported for a smooth muscle MLCK biosensor (24). The expression of the skMLCK biosensor is readily apparent with fluorescence images of intact muscle (Fig. 4B).

The rate and extent of skMLCK activation was proportional to the electrical stimulation frequency from 0.2 to 150 Hz (Fig. 4, C and D). Normalization of the responses after maximal activation of the CaM biosensor with Ca2+/CaM in permeabilized fibers showed 24 ± 7 and 59 ± 7% activation at 10 and 150 Hz, respectively (Fig. 4E). Stimulation at 50 and 300 Hz resulted in activation similar to that obtained at 150 Hz. Thus, Ca2+/CaM appears to be limiting for skMLCK biosensor activation at high frequencies of contraction.

Maximal activation and inactivation rates were determined for skMLCK in relation to force development and relaxation (Fig. 4F). SkMLCK activation occurred rapidly with no apparent latency relative to force development (Fig. 4F, inset). The activation and inactivation rate constants were 10.6 ± 0.2 and 2.8 ± 0.2 s-1, respectively, whereas the rate constants for force development and relaxation were 38.2 ± 1.7 and 33.4 ± 2.3 s-1, respectively.


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
Potentiation of twitch force is a well established physiological property of fast-twitch skeletal muscle that occurs in response to repetitive stimulation (1, 2). Reports that RLCf is phosphorylated in response to electrical stimulation (5, 25) and that the magnitude of twitch force potentiation is proportional to the extent of RLCf phosphorylation (3, 5, 13) represented early evidence that RLCf was a biochemical mechanism responsible for frequency-dependent twitch force potentiation. In striated muscle, Ca2+ activation of contraction is primarily mediated through a thin filament regulatory system, troponin-tropomyosin. Although sarcomeric RLC phosphorylation has no effect on actin-activated ATPase activity of striated muscle myosins, sarcomeric RLC phosphorylation in both skinned skeletal muscle fibers and skinned cardiac muscle fibers leads to a leftward shift in the force-pCa relationship, thus increasing the calcium sensitivity of the myofilaments (Ca2+ sensitization) (4, 26–28). Phosphorylation of RLC increases the cross bridge transition to the strongly bound, force-generating state, whereas slowing the rate of decay of the force-generating state. Repetitive increases in cytosolic Ca2+ necessary for contractile responses would also result in Ca2+ binding to CaM and Ca2+/CaM then binding to skMLCK for activation (29, 30). Based on the known biochemical properties of skMLCK, a quantitative model predicted 1) the importance of the interpulse interval for fractional kinase activation; 2) limiting kinase activity so that RLCf was phosphorylated in seconds, not milliseconds; and 3) the much greater kinase activity relative to the phosphatase activity so that a small fractional activation of kinase resulted in RLCf phosphorylation that was sustained (4, 13).


Figure 4
View larger version (39K):
[in this window]
[in a new window]

  		FIGURE 4.
Activation of skMLCK measured by FRET. A, Ca2+-dependent skMLCK activity and kinase activation measured by FRET in cell lysates from transfected COS cells. B, bright field and epifluorescent images of lumbrical muscles of a transgenic mouse. Images are shown prior to (upper panels) and following (lower panels) dissection from the hind paw. The marker indicates 1 mm. C, representative 480/535 fluorescence emissions in response to electrical stimulation of a lumbrical muscle at 0.2 (red), 5(light blue), 10 (green), 25 (dark blue), and 150 (black) Hz. D, frequency response curve for 480/535 fluorescence emission with electrical stimulation of lumbrical muscles at 0.2–300 Hz. E, quantitative measure of skMLCK activation in response to 10- or 150-Hz electrical stimulation as measured by the 480/535 fluorescence emission. Results are expressed as a percentage of the response after Ca2+/CaM treatment in permeabilized fibers. F, representative force tracing (black) and curve-fit 480/535 fluorescence emission (green) in response to 150-Hz electrical stimulation. Values represent mean ± S.E. (n = 3–7).

 
Recently, we provided genetic support for this model using skMLCK knock-out mice (6). In contrast to wild-type littermates, electrical stimulation was without effect on RLCf phosphorylation in response to electrical stimulation in skMLCK knock-out mice. This loss of RLCf phosphorylation was accompanied by markedly reduced potentiation of twitch force. These results with skMLCK knock-out mice provide direct evidence for the involvement of skMLCK-mediated RLCf phosphorylation to induce potentiation of twitch force in fast-twitch skeletal muscle.

Because phosphorylation of RLCf by skMLCK is dependent on both the catalytic activity of skMLCK as well as the binding of Ca2+/CaM to skMLCK, we determined whether either skMLCK or CaM was limiting to the frequency-dependent RLCf phosphorylation and the subsequent potentiation of twitch force. We show that overexpression of skMLCK results in a gain of function at the level of RLCf phosphorylation and twitch force potentiation without a corresponding up-regulation in CaM expression. Therefore, in fast-twitch EDL muscle, the amount of skMLCK appears limiting for RLCf phosphorylation.

Reports of robust frequency-dependent potentiation of twitch force have thus far been restricted to fast-twitch muscle (1). Previously, differences in the magnitude of responses to twitch potentiation and RLC phosphorylation have been reported in rat fast-twitch white (type IIb fibers) versus slow-twitch red (type I fibers) skeletal muscle (13). Greater RLC phosphorylation was suggested to be the consequence of a 14-fold greater kinase to phosphatase activity in fast versus slow muscle. It was also noted that fast-twitch, red (type IIa fibers) contained less skMLCK, resulting in less RLC phosphorylation with electrical stimulation (6). Consistent with this finding, we observed that expression of skMLCK in wild-type mouse soleus muscle was 10% of EDL muscle. Furthermore, twitch force potentiation in wild-type mouse soleus muscle was limited to an 8–14% increase. We considered that the lack of significant potentiation in soleus muscle was due to minimal skMLCK-induced RLC phosphorylation and that overexpression of skMLCK in soleus muscle would result in twitch force potentiation similar to that observed in wild-type fast-twitch EDL muscle. Despite achieving transgene expression similar in magnitude in both EDL and soleus muscle, overexpression of skMLCK in soleus muscle did not mediate a robust twitch force potentiation despite a marked frequency-dependent phosphorylation of both RLCf and RLCs in transgenic soleus muscle.

Like slow-twitch skeletal muscle fibers, cardiac ventricular myofibrils also contain RLCs (also called ventricular RLC; RLCv; and MLC2v). Nevertheless, results from studies investigating the effects of RLCs phosphorylation on force development in intact cardiac muscle are in stark contrast to those observed in soleus muscle in the current investigation. In skinned cardiac muscle fibers, phosphorylation of RLCs results in increased force and rate of cross bridge recruitment at submaximal Ca2+ concentrations (15, 31). Likewise, transgenic mice expressing a non-phosphorylatable RLCs exhibit reduced systolic pressure and contractility, indicating that phosphorylation of RLCs affects force development in intact cardiac muscle (32).

The reason for the lack of twitch potentiation with substantial RLC phosphorylation in soleus muscles from transgenic mice is not clear. C57BL/6 mouse EDL muscle contains 18% type IIa and 70% type IIb fibers (33). In contrast, the mouse soleus muscle contains as little as 6% type IIb fibers with 59% type IIa and 35% type I fibers (34). Thus, the potentiation of contraction is correlated to type IIb fibers. Functional studies relating RLC phosphorylation to isometric twitch force potentiation in type IIa fibers are not reported, although these fibers contain a smaller amount of skMLCK than type IIb fibers, resulting in less RLC phosphorylation with repetitive stimulation (13). Electron micrographs of isolated thick filaments show that the myosin heads undergo a conformational change with phosphorylation that moves them away from the backbone of the thick filament, allowing the myosin head to be in closer proximity to the thin actin filament (35, 36). Changing the spacing between thin and thick filaments by osmotic compression or elongating sarcomere length brings the myosin heads in closer proximity to the actin filament, mimicking the effect of RLC phosphorylation (36). Potentially, the interfilament spacing of type I and type IIa fibers may be sufficiently small for optimal force development even if RLC is not phosphorylated. There may also be differences in RLC and myosin heavy chain interactions of the different myosin isoforms that affect head displacements or other biochemical differences intrinsic to the muscle fiber types.

Over the past decade, FRET has been used to measure many real-time cellular signaling events (37). It has been suggested that numerous CaM-dependent proteins must compete for CaM, which is available in a limited pool in cells in culture (38, 39) and cardiomyocytes (40). Transgenic mice expressing a smooth muscle MLCK (smMLCK) CaM biosensor showed that the kinase was not fully activated under conditions of maximal increases in cytosolic Ca2+ concentrations in smooth muscle cells in bladder tissue (17). The smMLCK transgene was expressed at only 30% of the endogenous kinase and thus served as a reporter for Ca2+/CaM binding and activation. In the present study, we have examined skMLCK using a similar CaM biosensor to study calmodulin binding and activation of skMLCK in intact skeletal muscle fibers. Results show 60% maximal activation of the kinase. However, because the skMLCK transgene is expressed at 20-fold greater amounts than the endogenous kinase, we conclude that CaM is unlikely to be a limiting factor for skMLCK activation in wild-type skeletal muscle. This conclusion is consistent with enhanced frequency-dependent RLCf phosphorylation in EDL muscle in transgenic muscle with unaltered CaM expression.

Computer modeling based on the biochemical Ca2+ binding properties suggests that Ca2+ binds to troponin and CaM at a similar rate (30). Our results show that skeletal muscle force development increases at a faster rate than CaM binding to skMLCK, indicating that conformational changes that are part of the excitation-contraction coupling events distal to Ca2+ binding to troponin occur more rapidly than the formation of the Ca2+/CaM/skMLCK complex. Rapid kinetic measurements indicate a diffusion controlled, bimolecular association of Ca2+/CaM with skMLCK (41). Furthermore, the association of Ca2+/CaM with skMLCK results in rapid activation without an apparent conformational latency. Although Ca2+ dissociates faster from CaM than from troponin (30), the rate of dissociation of Ca2+ from CaM bound to skMLCK is slower, resulting in dissociation of CaM from the kinase at 3 s-1 (42). This biochemical dissociation rate is similar to the rate measured herein in vivo (2.8 s-1). Importantly, this slow rate of CaM dissociation from skMLCK allows for a longer period of skMLCK activation between Ca2+ transients at low frequencies of contraction. Thus, we provide insights into the mechanism by which RLC phosphorylation leads to a biochemical memory for enhanced twitch force.

In conclusion, skMLCK is limiting for frequency-dependent phosphorylation of RLC in fast- and slow-twitch skeletal muscles. RLC phosphorylation enhances twitch-force potentiation only in fast-twitch EDL muscle, presumably in type IIb fibers. Consistent with a gain of skMLCK function in transgenic skeletal muscle, FRET analysis shows that CaM is only partially limiting to skMLCK activation in transgenic mice and thus unlikely to be limiting under normal conditions in wild-type mice.


   FOOTNOTES
 
* This work was supported by National Institutes of Health grants HL29043 and HL26043 and grants from the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (to J. T. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{diamondsuit} This article was selected as a Paper of the Week. Back

1 Supported as a postdoctoral fellow on National Institutes of Health Training Grant T32HL007360. Back

2 To whom correspondence should be addressed. Tel.: 214-645-6058; Fax: 214-645-6049; E-mail: james.stull{at}utsouthwestern.edu.

3 The abbreviations used are: MLCK, myosin light chain kinase; skMLCK, skeletal muscle MLCK; smMLCK, smooth muscle MLCK; RLC, regulatory light chain of myosin; RLCf, fast-twitch RLC; RLCs, slow-twitch RLC; CaM, calmodulin; FRET, fluorescence resonance energy transfer; MYPT, myosin phosphatase-targeting subunit; EDL, extensor digitorum longus; HSA, human skeletal {alpha}-actin; MOPS, 4-morpholinepropanesulfonic acid. Back


   ACKNOWLEDGMENTS
 
We thank Jeffrey Chamberlain for the kind gift of the HSA promoter; John Shelton for assistance with epifluorescence imaging; Anthony Persechini for the calmodulin sensor cDNA, Tara Billman for animal care; and Tzu-Ming Wang for Matlab programming.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Close, R., and Hoh, J. F. (1968) J. Physiol. (Lond.) 197, 461-477[Abstract/Free Full Text]
  2. Krarup, C. (1981) J. Physiol. (Lond.) 311, 355-372[Abstract/Free Full Text]
  3. Manning, D. R., and Stull, J. T. (1982) Am. J. Physiol. 242, C234-C241[Medline] [Order article via Infotrieve]
  4. Sweeney, H. L., Bowman, B. F., and Stull, J. T. (1993) Am. J. Physiol. 264, C1085-C1095[Medline] [Order article via Infotrieve]
  5. Klug, G. A., Botterman, B. R., and Stull, J. T. (1982) J. Biol. Chem. 257, 4688-4690[Abstract/Free Full Text]
  6. Zhi, G., Ryder, J. W., Huang, J., Ding, P., Chen, Y., Zhao, Y., Kamm, K. E., and Stull, J. T. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 17519-17524[Abstract/Free Full Text]
  7. Sale, D. G. (2002) Exerc. Sport Sci. Rev. 30, 138-143[CrossRef][Medline] [Order article via Infotrieve]
  8. Baudry, S., and Duchateau, J. (2007) J. Appl. Physiol. 102, 1394-1401[Abstract/Free Full Text]
  9. Childers, M. K., and McDonald, K. S. (2004) Muscle Nerve 29, 313-317[CrossRef][Medline] [Order article via Infotrieve]
  10. Clarkson, P. M., Hoffman, E. P., Zambraski, E., Gordish-Dressman, H., Kearns, A., Hubal, M., Harmon, B., and Devaney, J. M. (2005) J. Appl. Physiol. 99, 564-569[Abstract/Free Full Text]
  11. Crow, M. T., and Kushmerick, M. J. (1982) J. Biol. Chem. 257, 2121-2124[Abstract/Free Full Text]
  12. Westwood, S. A., Hudlicka, O., and Perry, S. V. (1984) Biochem. J. 218, 841-847[Medline] [Order article via Infotrieve]
  13. Moore, R. L., and Stull, J. T. (1984) Am. J. Physiol. 247, C462-C471[Medline] [Order article via Infotrieve]
  14. Moore, R. L., Houston, M. E., Iwamoto, G. A., and Stull, J. T. (1985) J. Cell. Physiol. 125, 301-305[CrossRef][Medline] [Order article via Infotrieve]
  15. Sweeney, H. L., and Stull, J. T. (1986) Am. J. Physiol. 250, C657-C660[Medline] [Order article via Infotrieve]
  16. Tran, Q.-K., Black, D. J., and Persechini, A. (2005) Cell Calcium 37, 541-553[CrossRef][Medline] [Order article via Infotrieve]
  17. Isotani, E., Zhi, G., Lau, K. S., Huang, J., Mizuno, Y., Persechini, A., Geguchadze, R., Kamm, K. E., and Stull, J. T. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 6279-6284[Abstract/Free Full Text]
  18. Persechini, A., and Cronk, B. (1999) J. Biol. Chem. 274, 6827-6830[Abstract/Free Full Text]
  19. Crawford, G. E., Faulkner, J. A., Crosbie, R. H., Campbell, K. P., Froehner, S. C., and Chamberlain, J. S. (2000) J. Cell Biol. 150, 1399-1410[Abstract/Free Full Text]
  20. Muscat, G. E., Perry, S., Prentice, H., and Kedes, L. (1992) Gene Expr. 2, 111-126[Medline] [Order article via Infotrieve]
  21. Agbulut, O., Huet, A., Niederlander, N., Puceat, M., Menasche, P., and Coirault, C. (2007) J. Biol. Chem. 282, 10465-10471[Abstract/Free Full Text]
  22. Kamm, K., Hsu, L., Kubota, Y., and Stull, J. (1989) J. Biol. Chem. 264, 21223-21229[Abstract/Free Full Text]
  23. Nunnally, M. H., Rybicki, S. B., and Stull, J. T. (1985) J. Biol. Chem. 260, 1020-1026[Abstract/Free Full Text]
  24. Geguchadze, R., Zhi, G., Lau, K. S., Isotani, E., Persechini, A., Kamm, K. E., and Stull, J. T. (2004) FEBS Lett. 557, 121-124[CrossRef][Medline] [Order article via Infotrieve]
  25. Stull, J. T., and High, C. W. (1977) Biochem. Biophys. Res. Commun. 77, 1078-1083[CrossRef][Medline] [Order article via Infotrieve]
  26. Metzger, J. M., Greaser, M. L., and Moss, R. L. (1989) J. Gen. Physiol. 93, 855-883[Abstract/Free Full Text]
  27. Patel, J. R., Diffee, G. M., Huang, X. P., and Moss, R. L. (1998) Biophys. J. 74, 360-368[Medline] [Order article via Infotrieve]
  28. Sweeney, H. L., and Stull, J. T. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 414-418[Abstract/Free Full Text]
  29. Blumenthal, D. K., and Stull, J. T. (1980) Biochemistry 19, 5608-5614[CrossRef][Medline] [Order article via Infotrieve]
  30. Robertson, S. P., Johnson, J. D., and Potter, J. D. (1981) Biophys. J. 34, 559-569[Medline] [Order article via Infotrieve]
  31. Stelzer, J. E., Patel, J. R., and Moss, R. L. (2006) J. Gen. Physiol. 128, 261-272[Abstract/Free Full Text]
  32. Dias, F. A. L., Walker, L. A., Arteaga, G. M., Walker, J. S., Vijayan, K., Pena, J. R., Ke, Y., Fogaca, R. T. H., Sanbe, A., Robbins, J., and Wolska, B. M. (2006) J. Mol. Cell. Cardiol. 41, 330-339[CrossRef][Medline] [Order article via Infotrieve]
  33. Gorselink, M., Drost, M. R., de Brouwer, K. F., Schaart, G., van Kranenburg, G. P., Roemen, T. H., van Bilsen, M., Charron, M. J., and van der Vusse, G. J. (2002) Am. J. Physiol. 282, E348-E354
  34. Totsuka, Y., Nagao, Y., Horii, T., Yonekawa, H., Imai, H., Hatta, H., Izaike, Y., Tokunaga, T., and Atomi, Y. (2003) J. Appl. Physiol. 95, 720-727[Abstract/Free Full Text]
  35. Levine, R. J. C., Kensler, R. W., Yang, Z., Stull, J. T., and Sweeney, H. L. (1996) Biophys. J. 71, 898-907[Medline] [Order article via Infotrieve]
  36. Yang, Z., Stull, J. T., Levine, R. J., and Sweeney, H. L. (1998) J. Struct. Biol. 122, 139-148[CrossRef][Medline] [Order article via Infotrieve]
  37. Zhang, J., Campbell, R. E., Ting, A. Y., and Tsien, R. Y. (2002) Nat. Rev. Mol. Cell Biol. 3, 906-918[CrossRef][Medline] [Order article via Infotrieve]
  38. Black, D. J., Tran, Q. K., and Persechini, A. (2004) Cell Calcium 35, 415-425[CrossRef][Medline] [Order article via Infotrieve]
  39. Persechini, A., and Stemmer, P. M. (2002) Trends Cardiovasc. Med. 12, 32-37[CrossRef][Medline] [Order article via Infotrieve]
  40. Maier, L. S., Ziolo, M. T., Bossuyt, J., Persechini, A., Mestril, R., and Bers, D. M. (2006) J. Mol. Cell. Cardiol. 41, 451-458[CrossRef][Medline] [Order article via Infotrieve]
  41. Bowman, B. F., Peterson, J. A., and Stull, J. T. (1992) J. Biol. Chem. 267, 5346-5354[Abstract/Free Full Text]
  42. Gallagher, P. J., Herring, B. P., and Stull, J. T. (1997) J. Muscle Res. Cell Motil. 18, 1-16[Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. Huang, J. M. Shelton, J. A. Richardson, K. E. Kamm, and J. T. Stull
Myosin Regulatory Light Chain Phosphorylation Attenuates Cardiac Hypertrophy
J. Biol. Chem., July 11, 2008; 283(28): 19748 - 19756.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
R. M. Murphy, T. L. Dutka, and G. D. Lamb
Hydroxyl radical and glutathione interactions alter calcium sensitivity and maximum force of the contractile apparatus in rat skeletal muscle fibres
J. Physiol., April 15, 2008; 586(8): 2203 - 2216.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/28/20447    most recent
M702927200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryder, J. W.
Right arrow Articles by Stull, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryder, J. W.
Right arrow Articles by Stull, J. T.
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journa